- Home
- SIG vs ZLAB Comparison
SIG vs ZLAB Comparison
Compare SIG & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIG
- ZLAB
- Stock Information
- Founded
- SIG 1950
- ZLAB 2013
- Country
- SIG Bermuda
- ZLAB China
- Employees
- SIG N/A
- ZLAB N/A
- Industry
- SIG Consumer Specialties
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- SIG Consumer Discretionary
- ZLAB Health Care
- Exchange
- SIG Nasdaq
- ZLAB Nasdaq
- Market Cap
- SIG 3.3B
- ZLAB 3.6B
- IPO Year
- SIG N/A
- ZLAB 2017
- Fundamental
- Price
- SIG $83.94
- ZLAB $35.17
- Analyst Decision
- SIG Buy
- ZLAB Buy
- Analyst Count
- SIG 6
- ZLAB 5
- Target Price
- SIG $88.33
- ZLAB $54.28
- AVG Volume (30 Days)
- SIG 1.3M
- ZLAB 987.9K
- Earning Date
- SIG 06-03-2025
- ZLAB 08-05-2025
- Dividend Yield
- SIG 1.52%
- ZLAB N/A
- EPS Growth
- SIG N/A
- ZLAB N/A
- EPS
- SIG 0.86
- ZLAB N/A
- Revenue
- SIG $6,734,600,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- SIG $1.41
- ZLAB $44.07
- Revenue Next Year
- SIG $1.07
- ZLAB $49.13
- P/E Ratio
- SIG $97.15
- ZLAB N/A
- Revenue Growth
- SIG N/A
- ZLAB 43.72
- 52 Week Low
- SIG $45.55
- ZLAB $16.01
- 52 Week High
- SIG $106.28
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- SIG 65.32
- ZLAB 48.52
- Support Level
- SIG $77.84
- ZLAB $34.55
- Resistance Level
- SIG $83.14
- ZLAB $36.73
- Average True Range (ATR)
- SIG 2.73
- ZLAB 1.35
- MACD
- SIG -0.29
- ZLAB -0.61
- Stochastic Oscillator
- SIG 90.36
- ZLAB 7.35
About SIG Signet Jewelers Limited
Signet Jewelers Ltd is a retailer of diamond jewelry. Its merchandise mix includes bridal, fashion, watches, and others. The bridal category includes engagement, wedding and anniversary purchases. Its segments are the North America segment, the International segment, and the Other segment. The North America segment contributes to the majority of the revenue. The North America segment generates revenue from Mall and Off-Mall & Outlet.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.